Dr Pernille Holtedahl CAP0057
Additional written evidence from Dr. Pernille Holtedahl, Imperial College London
I’d like to briefly cover two points which we didn’t discuss, but which are central to the overall subject of The Role of Natural Capital in the Green Economy and to re-iterate a point I made in my deposition.
1. On the opportunities that voluntary biodiversity action by the private sector holds. Such actions are sometimes pointed to as an alternative to regulatory-driven actions or as somehow miraculously expected to follow in the wake of transparency and awareness initiatives such as TNFD. However, in a study carried out last year (Holtedahl et al., 2023, Corporate action on biodiversity: an exploration of drivers), we found that:
It follows that:
2. On where to focus biodiversity efforts -where is the biggest bang for the buck? Since 70% of UK’s land area is farmed and since agriculture is the primary driver of biodiversity loss, the management of agriculture must remain a key focus of the Government’s efforts to improve biodiversity. The members of the committee are aware of this and I know the Government is already developing several schemes for farmers, so the purpose of raising this point is simply to bring it to the foreground of the committee’s continued deliberations – especially since most of the committee’s discussions were around BNG which targets developers/the built environment.
In a 2022 study (Future of Food Part 3 – Can Markets Save Nature? Investing in Nature to Tackle Biodiversity Loss and Enhance Food Security, Oct 2022), colleagues and I highlighted the feedback loops between nature loss, climate change and food security and discussed eight instruments through which private investors can get exposure to the sector.
3. Finally, I’d like to re-iterate the point I made in my oral evidence that international evidence on the effectiveness of biodiversity offset markets is very mixed and indeed show predominantly poor success rates in achieving these markets’ objectives. Study 1 and Study 2 provide some evidence on this (meta studies). I bring up this point to underline the crucial role monitoring and evaluation will have to play in BNG and other markets going forward. And to – again- temper expectations on what we can expect from these new instruments/ markets.
*****************
April 2024